Drug-tolerant persister cells in lymphoid malignancies: from mechanisms to therapeutic opportunities - Quiz - MDSpire

Drug-tolerant persister cells in lymphoid malignancies: from mechanisms to therapeutic opportunities

  • By

  • Meng Li

  • Suping Tang

  • Peng Yang

  • Hao Zhou

  • July 15, 2026

Share

Original Source(s)

Drug-tolerant persister cells in lymphoid malignancies: from mechanisms to therapeutic opportunities

  • by Meng Li, Suping Tang, Peng Yang, Hao Zhou

  • July 15, 2026

Related Content

Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab

Evaluation of an interpretable deep-learning model for the automated plan review of intensity-modulated radiation therapy

Proteomics and transcriptomics reveal molecular subtypes and biomarkers of advanced cutaneous T-cell lymphoma